CIK 0001724521
- Large accelerated filer
Arcus Biosciences, Inc.
Sign in to watch- Ticker
- RCUS
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 473898435
- Phone
- +1 510-694-6200
- Business address
- 3928 POINT EDEN WAY, HAYWARD, CA, 94545
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $84,810
- in 1 filing, $85K under 10b5-1 plans
Net −$84,810. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 59 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-03-08 | Tang Carolyn C. General Counsel | Grant or award · Stock Option (right to buy) | +65,000 | 65,000 | ||
| 2022-03-08 | Goeltz II Robert C. Chief Financial Officer | Grant or award | +15,500 | 22,519 | ||
| 2022-03-08 | Goeltz II Robert C. Chief Financial Officer | Grant or award · Stock Option (right to buy) | +62,500 | 62,500 | ||
| 2022-03-08 | Jarrett Jennifer Chief Operating Officer | Grant or award | +31,250 | 121,845 | ||
| 2022-03-08 | Jarrett Jennifer Chief Operating Officer | Grant or award · Stock Option (right to buy) | +125,000 | 125,000 | ||
| 2022-03-08 | Jaen Juan C. President | Grant or award | +31,250 | 232,407 | ||
| 2022-03-08 | Jaen Juan C. President | Grant or award · Stock Option (right to buy) | +125,000 | 125,000 | ||
| 2022-03-08 | ROSEN TERRY J Chief Executive Officer | Grant or award | +65,000 | 276,570 | ||
| 2022-03-08 | ROSEN TERRY J Chief Executive Officer | Grant or award · Stock Option (right to buy) | +275,000 | 275,000 | ||
| 2022-03-07 | ROSEN TERRY J Chief Executive Officer | Gift | −321,074 | 0 | ||
| 2022-02-28 | Jaen Juan C. President | Gift | −350,000 | 1,222,240 | ||
| 2021-12-20 | Jarrett Jennifer Chief Operating Officer | Sale | −11,099 | $40.88 | $454K | 114,318 |
| 2021-12-20 | Jarrett Jennifer Chief Operating Officer | Sale | −20,923 | $41.70 | $872K | 93,395 |
| 2021-12-20 | Jarrett Jennifer Chief Operating Officer | Sale | −2,800 | $42.23 | $118K | 90,595 |
| 2021-12-17 | Tang Carolyn C. General Counsel | Sale | −138 | $38.79 | $5K | 18,048 |
| 2021-12-17 | Tang Carolyn C. General Counsel | Sale | −88 | $39.67 | $3K | 17,960 |
| 2021-12-17 | Tang Carolyn C. General Counsel | Sale | −171 | $40.57 | $7K | 17,789 |
| 2021-12-17 | Tang Carolyn C. General Counsel | Sale | −225 | $41.42 | $9K | 17,564 |
| 2021-12-17 | Goeltz II Robert C. Chief Financial Officer | Sale | −138 | $38.79 | $5K | 7,502 |
| 2021-12-17 | Goeltz II Robert C. Chief Financial Officer | Sale | −88 | $39.67 | $3K | 7,414 |
Page 15 of 20 · 381 trades